Praveen Tipirneni, Morphic Therapeutic CEO

Lil­ly dis­clos­es its first biotech ac­qui­si­tion of the year, buy­ing Mor­phic for $3.2B

Eli Lil­ly said Mon­day it plans to pay $3.2 bil­lion in cash for Mor­phic Ther­a­peu­tic, a biotech work­ing on oral in­te­grin …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.